Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma

Metastatic clear cell renal cell carcinoma (mccRCC) benefits from several treatment options in the first-line setting with VEGFR inhibitors and/or immunotherapy including anti-PD-L1 or anti-PD1 agents. Identification of predictive biomarkers is highly needed to optimize patient care. Circulating mar...

Descripción completa

Detalles Bibliográficos
Autores principales: Montemagno, Christopher, Hagege, Anais, Borchiellini, Delphine, Thamphya, Brice, Rastoin, Olivia, Ambrosetti, Damien, Iovanna, Juan, Rioux-Leclercq, Nathalie, Porta, Camillio, Negrier, Sylvie, Ferrero, Jean-Marc, Chamorey, Emmanuel, Pagès, Gilles, Dufies, Maeva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714499/
https://www.ncbi.nlm.nih.gov/pubmed/33299657
http://dx.doi.org/10.1080/2162402X.2020.1846901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714499/
https://www.ncbi.nlm.nih.gov/pubmed/33299657
http://dx.doi.org/10.1080/2162402X.2020.1846901

Ejemplares similares